Trademark Overview
On Wednesday, June 11, 2025, a trademark application was filed for QUBLINTROS with the United States Patent and Trademark Office. The USPTO has given the QUBLINTROS trademark a serial number of 99228715. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, June 11, 2025. This trademark is owned by Amgen Inc.. The QUBLINTROS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations; pharmaceutical preparations used for the treatment of cancer and immune diseases and conditions; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of lupus erythematosus, rheumatoid arthritis, multiple sclerosis, neuromyelitis optica and systemic sclerosis